Skip to main content
. 2016 Dec 28;8(6):10071–10084. doi: 10.18632/oncotarget.14336

Table 5. Experimental and predicted inhibitory activities of 17 compounds by 3D-QSAR model.

CLompounds Experimental pIC50 Predicted pIC50 Residual error
1 4.27240 4.24780 0.0245988
2 4.44473 4.37745 0.0672809
3 4.67445 4.70636 -0.0319126
4 4.12084 4.19534 -0.0745045
5 3.94868 3.93447 0.0142062
6a 3.99007 3.97291 0.0171585
7 4.11364 4.13921 -0.0255712
8 4.01952 4.03475 -0.0152263
9a 3.79952 3.99636 -0.196836
17 4.03403 4.01796 0.0160717
19a 3.97562 3.99842 -0.022796
20 4.11556 4.04926 0.0663042
21 3.80137 3.87671 -0.0753358
22 3.97562 3.93744 0.0381821
23 3.78648 3.81034 -0.0238569
24a 4.11556 4.04527 0.0702946
28 3.79945 3.77969 0.0197632

a Compounds were selected as the test sets while the rest ones were in the training sets.